Document Detail

Type 1 Ig-E mediated allergy to human insulin, insulin analogues and beta-lactam antibiotics.
Jump to Full Text
MedLine Citation:
PMID:  23197216     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Insulin, a crucial therapeutic agent for diabetes mellitus, has been rarely associated with hypersensitivity events. We present a 69-year-old type-2 diabetic patient with urticariform lesions on the sites of subcutaneous injection of insulin. The patient denied any known allergies, except for an unspecific cutaneous reaction after intramuscular penicillin administration in childhood. Prick tests revealed positive reactions to all tested human insulins and insulin analogues. Serum IgE levels were above normal range and RAST tests were positive for human, bovine and porcine insulins, as well as beta-lactams. Type 1 IgEmediated allergy to insulin analogues demands a prompt diagnosis and represents a significant therapeutic challenge in diabetic patients.
Authors:
Pedro Andrade; Luísa Barros; Margarida Gonçalo
Related Documents :
2196806 - Mechanism of action of oral contraceptives on carbohydrate metabolism at the cellular l...
23393686 - The pancreatic beta cells in human type 2 diabetes.
6344826 - Glycosaminoglycan deposition in the acanthosis nigricans lesions of the polycystic ovar...
24342036 - Relevance of beta-cell function for improved glycemic control after gastric bypass surg...
10807746 - Well-defined regions of apolipoprotein b-100 undergo conformational change during its i...
22471336 - Detection of kcnj11 gene mutations in a family with neonatal diabetes mellitus: implica...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anais brasileiros de dermatologia     Volume:  87     ISSN:  1806-4841     ISO Abbreviation:  An Bras Dermatol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0067662     Medline TA:  An Bras Dermatol     Country:  Brazil    
Other Details:
Languages:  eng     Pagination:  917-9     Citation Subset:  IM    
Affiliation:
Dermatology and Venereology Service, Teaching Hospitals of University of Coimbra, Coimbra, Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): An Bras Dermatol
Journal ID (iso-abbrev): An Bras Dermatol
Journal ID (publisher-id): An. bras. dermatol.
ISSN: 0365-0596
ISSN: 1806-4841
Publisher: Sociedade Brasileira de Dermatologia
Article Information
Download PDF
http://www.anaisdedermatologia.org.brhttp://www.scielo.br/abd©2012 by Anais Brasileiros de Dermatologia
open-access:
Received Day: 05 Month: 8 Year: 2011
Accepted Day: 08 Month: 11 Year: 2011
Print publication date: Season: Nov-Dec Year: 2012
Volume: 87 Issue: 6
First Page: 917 Last Page: 919
PubMed Id: 23197216
ID: 3699913
DOI: 10.1590/S0365-05962012000600018

Type 1 Ig-E mediated allergy to human insulin, insulin analogues and beta-lactam antibiotics*
Pedro Andrade1
Luísa Barros2
Margarida Gonçalo3
1M. D. - Intern of Dermatology and Venereology - Dermatology and Venereology Service, Teaching Hospitals of University of Coimbra (Universidade de Coimbra, EPE) - Coimbra, Portugal
2M.D. - Specialist in Endocrinology - Hospital Assistant - Endocrinology Service, Teaching Hospitals of University of Coimbra (Universidade de Coimbra, EPE) - Coimbra, Portugal
3M.D. - Specialist in Dermatology and Venereology - Service Head - Dermatology and Venereology Service, Teaching Hospitals of University of Coimbra (Universidade de Coimbra, EPE) - Coimbra, Portugal
Correspondence: Mailing address: Pedro Andrade, Serviço de Dermatologia e Venereologia - Hospitais da Universidade de Coimbra, Praceta Mota Pinto 3000-075, Coimbra - Portugal, E-mail: pedro.andrade@portugalmail.com

INTRODUCTION

Insulin is an essential therapeutic agent for the management of diabetes mellitus. Immediate hypersensitivity to recombinant human insulin preparations and insulin analogues is rare and may be associated with hypersensitivity to other molecules.


CASE REPORT

We present the case of a 69-year-old male with type 2 diabetes mellitus diagnosed at the age of 63, that due to insufficient glycemic control on oral therapy alone and intolerance to some oral antidiabetics, was treated with premixed insulin analogues lispro and lispro protamine (Humalog Mix 25TM) during the previous two years. The onset of pruriginous urticariform abdominal plaques with peripheral pale halos was observed, arising within minutes at the sites of subcutaneous insulin administration and occasionally at distant sites, recurring at nearly every insulin injection in the past year (Figure 1). Lesions regressed spontaneously in the space of a few minutes or hours. Glycemic control was acceptable (serum glycated hemoglobin A1c levels were 53mmol/mol - 7.0% - at presentation) and apparently unaffected by the cutaneous reaction.

The patient presented class I obesity (body mass index 31), dyslipidemia and arterial hypertension and was regularly treated with oral atorvastatin 20mg o.d., telmisartan 80mg o.d., hydrochlorothyazide 12.5mg o.d. and triflusal 300mg o.d.. No known allergies were reported, apart from a generalized erythematous cutaneous eruption of unclear nature following intramuscular penicillin injection in his childhood, which justified the avoidance of beta-lactam antibiotics ever since.

The diagnosis of immediate hypersensitivity to insulin analogue lispro was therefore suspected. Rechallenging administration of 2U of the regularly used insulin induced, in few minutes, a new pruriginous urticariform lesion at the site of the injection (Figure 2).

Prick tests using several different types of human insulin and insulin analogues were performed and all of them triggered positive reactions (papule diameters >3mm after 20minutes and >5mm after 60 minutes) (Table 1). Papules 5 and 7mm in diameter were observed 20 and 60 minutes after prick test with Merck ® histamine 10mg/ml solution (positive control), while no reaction was induced by isotonic sodium chloride solution (negative control).

Total serum IgE was three times above the normal limit (312UI/ml), with class 3 radioallergosorbent tests (RAST) for human, bovine and porcine insulins (13.2KU/L, 16.0KU/L and 14.3KU/L respectively). Interestingly, RAST for beta-lactam antibiotics were reported as Class 2 (1.0KU/L for penicillin G, 0.94KU/L for penicillin V, 0.87KU/L for ampicillin and 0.72KU/L for amoxycillin), and Class 0 for cefaclor (0.08KU/L).

These results allowed the confirmation of type 1 IgE-mediated hypersensitivity to human insulin and insulin analogues lispro, glargine and detemir. In addition, despite being insufficient for clear identification of hypersensitivity to beta-lactams, results concerning these antibiotics were considered relevant, based on the previous cutaneous eruption following penicillin treatment and the age of the patient, which in association with the lack of re-exposure to beta-lactams during several decades might explain the low serum concentration of specific IgE. Even so, it is interesting to notice the absence of cross-reactivity with cephalosporin.

After evaluation by an endocrinologist, insulin therapy was suspended and the patient began the intake of an oral anti-diabetic drug association. Cutaneous lesions did not recur and reasonable glycemic control was achieved after three months (fasting blood glucose levels ranging between 5,511.0mmol/L; serum glycated hemoglobin 55mmol/mol - 7.2%). As a high risk diabetic patient with several associated vascular and metabolic comorbidities, oral therapy has been considered insufficient and the patient has been proposed for insulin desensitization.


DISCUSSION

Urticaria may, in some cases, be triggered by drugs. 1 Immediate hypersensitivity to insulin is a rare condition among patients suffering from type 2 diabetes mellitus, particularly after the development of recombinant human insulins, which are clearly less immunogenic than former animal preparations. 2 In most cases it presents as immediate urticariform lesions or pruritus on the sites of the triggering injection, and in some instances also on other recent administration sites. 3 Due to the risk of serious reactions such as angioedema, anaphylactic shock and glycemic control deterioration, suspicion of insulin hypersensitivity should lead to therapy suspension and diagnosis confirmation by complete immunologic work-up. 4 Management of these patients might be challenging and should involve a multidisciplinary team. Rarely, additives such as meta-cresol, zinc or protamine, included in commercial insulin preparations, may be the responsible allergens, and this possibility was not excluded in the present case. 5

Insulin analogues have been considered as useful alternatives for insulin hypersensitivity patients, despite some rare demonstrations of their immunogenicity. 2,6,7 The present case corroborates the allergenic potential of short-acting and long-acting insulin analogues. The associated hypersensitivity to beta-lactam antibiotics is also noteworthy and has been previously reported in few cases of type 1 IgE-mediated insulin allergy. 2,8,9


Notes

Conflict of interest: None

Financial funding: None

fn01* Study carried out at the Dermatology and Venereology Service, Teaching Hospitals of University of Coimbra (Universidade de Coimbra, EPE) - Coimbra, Portugal

REFERENCES
1. Pereira LC. Urticaria medicamentosaAn Bras DermatolYear: 1968432672714247500
2. Heinzerling L,Raile K,Rochlitz H,Zuberbier T,Worm M. Insulin allergy: clinical manifestations and management strategiesAllergyYear: 20086314815518186805
3. Wessbecher R,Kiehn M,Stoffel E,Moll I. Management of insulin allergyAllergyYear: 20015691992011551264
4. Scheer BG,Sitz KV. Suspected insulin anaphylaxis and literature reviewJ Ark Med SocYear: 20019731131311233502
5. Pföhler C,Müller CS,Hasselmann DO,Tilgen W. Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case reportJ Med Case ReportsYear: 20082283
6. Barranco R,Herrero T,Tornero P,Barrio M,Frutos C,Rodríguez A,et al. Systemic allergic reaction by a human insulin analogAllergyYear: 20035853653712757463
7. Durand-Gonzalez KN,Guillausseau N,Pecquet C,Gayno JP. Glargine insulin is not an alternative in insulin allergyDiabetes CareYear: 200336221612832347
8. Caruso C,Alonzi C,Gaeta F,Viola M,Romano A. Same-patient allergy to ampicillin and human insulinAllergyYear: 2009641105110719243358
9. Jegasothy BV. Allergic reactions to insulinInt J DermatolYear: 1980191391416993380

Figures

[Figure ID: f01]
FIGURE 1 

Pruriginous urticariform abdominal plaques with peripheral pale halos arising within minutes at the sites of abdominal subcutaneous insulin administration



[Figure ID: f02]
FIGURE 2 

Pruriginous papule with 7mm in diameter arising 20 minutes after rechallenging 2U of Humalog Mix 25TM in the right arm



Tables
[TableWrap ID: t01] Table 1 

Prick tests with different human insulins and insulin analogues. NC: not considered due to local scratching


  Induration (mm)
  20 min 60 min
Sodium chloride (0.9%) 0 0
Histamine (10mg/ml) 5 7
Humalog Mix 25TM (Lilly) 7 NC
Humulin RegularTM (Lilly) 6 9
Humulin NPHTM (Lilly) 4 6
LantusTM (Sanofi-Aventis) 3 5
LevemirTM (Novo Nordisk) 3 7
Humulin M3TM (Lilly) 5 NC
ActrapidTM (Novo Nordisk) 8 NC


Article Categories:
  • Case Report

Keywords: Diabetes mellitus, type 2, Drug hypersensitivity, Insulin, Penicillins.

Previous Document:  Proliferating trichilemmal tumor of the nose.
Next Document:  Dermoscopic clues in the diagnosis of amelanotic and hypomelanotic malignant melanoma.